Kevin Balthaser
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | $446,000 | $1,490,790 |
| 2024 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | $444,000 | $1,102,163 |
| 2023 | Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | $444,000 | $2,344,432 |
Executive changes
Earnings-call appearances
-
Aclaris Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-07
Aclaris Therapeutics, Inc. (ACRS)
-
Aclaris Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-08
Aclaris Therapeutics, Inc. (ACRS)